melanoma
-
healthmRNA Vaccine Slashes Melanoma Recurrence Risk in Landmark Trial
A new mRNA cancer therapy from Merck and Moderna cuts melanoma recurrence or death risk by 49% over five years, offering new hope for late-stage patients.
-
health5-Minute Video Boosts Melanoma Detection in Underserved Areas
New study shows a short video significantly improves melanoma knowledge and self-screening in underserved communities, narrowing racial disparities.
-
healthCOVID-19 Lockdowns Linked to Drop in Melanoma Diagnoses, Study Finds
A study comparing Sweden and Australia reveals pandemic restrictions led to fewer melanoma diagnoses, raising concerns about delayed detection.
-
healthAI Pinpoints Melanoma Risk Years Early, Study Reveals
New AI models can identify individuals at significantly higher risk of developing melanoma within five years, potentially revolutionizing early detection and healthcare resource allocation.
-
sportsDick Vitale Faces Fifth Cancer Diagnosis: Melanoma Found in Lung and Liver
College basketball icon Dick Vitale announces his fifth cancer diagnosis, confirming melanoma in his lung and liver. He begins immunotherapy with his characteristic optimism.
-
healthMEL-SELF Trial Reveals Confidence Gaps in Melanoma Self-Examination
New baseline data from Australia's MEL-SELF trial shows 20% of melanoma survivors hadn't performed skin self-exams in a year-and 46% reported clinically significant fear of cancer recurrence.
-
healthNew Immune Markers Could Predict Melanoma Aggression and Treatment Response
Scientists identify three immune-related genes, LAG-3, TIGIT, and HAVCR2, that may predict melanoma progression and patient response to immunotherapy.